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II has been established (I ,ZJ that vasadilator therapy with 
angiotensin-canverdng enzyme inhibitors. hydmlazine and 
isosorbide dinitratc is eUeclivc for the !.on@term manage 
ment ofparicnts with chronic conlprtive heart failure. How- 
ever, many patients do not tolerate these vssodilatan or 
have continued deterioration despite therapy. Thus, the 
search continues for additional or allenn:ive pharmacotha- 
apeudc agents tbat may prove e&dive for the treatment of 
congestive hcan faibnr. 
Preliminary studies have indicated that ilosquinan (RTS 
49465. ?-Uuarc-t-methyt-3-methykulf@4quin&ne) may 
pmdua benctlcial systemic hemodynati effezts and improve 
cardii performance in patients with corgDtive heart ire 
(3.4). F@equbmn is a iong-acting balanced oral sy3temic 
vasodilator witb dilating cffectr on artcrird resistance vessels 
by which it &ts a vasndilato~ setion unknovm but its 
e&n may be mediated thmugh increases in cyclic guano- 
sinemo6&ospb~(~.Aubnalsnd~sstiletlasinvitm 
studies have suggested lbat Roreqtinan may have positive 
bmtmpic activity in addition to its vasodilator action cI_91. 
Becaw enhanced inotmpy and vasodilation may ptw 
cardial enagclics. it wcutd be 
changes in coronary hemodynamics in response to Rose 
qubmn. Alkmtionr in neumendowine function such as 
dented cntsbcdaminc levelr, increased plasma min activ- 
pkcms with ccageaive hat failure (10.11). However, 
vtii!ator drugs may not be unifom-despite similar 
char\pcs in systemic henwdynamka (12). The &cts of 
ml b&n extensively investigated. The purpose ff this tiy 
was. therefore, to wscss I) the immediate and long-tm 
systemic bemadynnmic actions of Rosequinm, 2) the immc- 
diate dPects of Roscquinm on coronary hemcdynamics end 
myoemdifd etwgctics. md 3) changes in neumendoaine 
function after tlmequinan therapy in @ems with cages- 




The ~~qcol was appmved by the Institutional Rcvim 
The study group consisted oi 13 patimts. 
I I men and 2 wnmen. with chmnic con&w heart f.&rc. 
The patimts mtgcd in age tium 51 to 74 years (ma 621. 
Board. ad written infomtcd consent was obtaiwd tiom catch 
The cause of hart faihwe was ischemic heart disease in four 
patients and primary dilated cardiomyopathy in nine. Elgbt 
ptkm pltpms mere studied at rest in a fmt&. nonsalad 
pat!mts wea in New Yak ffcart Association iimctimml 
clas III and five in class IV. The left ventricular ejection 
stab?. Admit&m& of VaYodiirs !vas dixoatnucd at least 
frdetion in these patients raged from 19% to 35% (mean 
20%) as mcasumd by either twdimensional cchocardii 
ra@y OT tadicmucleotklc scintigmphy. All patients had a 
history d congestive hart faihwe of 4 months’ to 6 years’ 
namic measurements were perfmmed and blood samples 
cdlected. The baseline hemodymmic mcasarements were 
quinan. 
ohrained every I5 min until two measunmcnts were within 
10% of each other. Floscquinm (Boots Pharmaceutial). 
C&datims_ Derived systemic and commry hemody- 
IM) mg orally. was thm administered and hemodynamic 
meas”rcme”ts and blood samples were obtained way 
nam*VCliCblCSWaeCSlCC~aSMbws:SysteCliCvlwu$r 
30 min for 2 h and tben evw 2 h for 8 h after this dose. The 
patients wearc allowed to cat 4 h &a the dose. Artmtal and 
msistmce ISVR. dywas-‘~m-5) = MAP - RAPPZD x SO. 
coronary sinus Mood samples were obtained lor measure- 
ment of oxygen satlm%tim, catccbolrlndns. atlial natriuretic 
where MAP is man art&d masum. 
factor and lactate with each hemcdynamic measwemmt. 
RAP is debt atrial 
After mmplction of tbe &h expaimental period, tbc cmc- 
nary sinus catheter was remwed. The padcnts w-e tbm 
placed on maimenmce thcmpy with t&zquinan. l&l mg 
once a day. md follmvcd up as outpatients for6 weeks. ARer 
6 weeks of therapy. tbcy were readmitted to the hospital far 
repcat invasive hcmodymmic monitorinS bcfmc and after 
tlosequinan admi&ratim. Tbe Swan&m catheter was 
removed on dav 2 after the raerat administmtim of Sac. 
24 h bcfam tbe study. AU patients were mainmbwd on stable prcssunsndCDisaudiacwrplt;pubnmmywacnlarresir 
dosesddigoxiltmdddtugsthatwrewitbb&ionthc tame (PVR, dynes&cm-~ = (MFAF - FCWP)KO x 80. 
mmnitQoftbes.tudyardaubsequeally%dministeredtheev0 wbelcMFwbmeanpuhmnuyartKy~ss~;mdFCWP 
nit@atterccmpletimcfthcstudy.M@mtsweremairP is pulmonary capilimy w&c pressare; coronary vascular 
laitted n a 2+&y slIdium-i-estrictcd dia. resistance 0%. dynews-‘sm-5) = [diastolic blood pres- 
Qstemle md fmrrml bemmlymndcs. The study was swc (DBFI - K!WP/CSBFj x SO. whcrc CBBF = coronary 
~c&amcd S the coronary cave unit. A triplolumrn balloon siwbloodSowstr&vnwkinda@Wl.~&)=SY~ 
flotation thcmtistor catheter Mmcricrm Bd\nudr Labora- MSP - FCWPI x 0.0136. where SVI is stroke volume index 
twy)wasinwtedintotbcri&tintemalju&rveinfw 
measuremettt of right at&l, ptdmmlary army and pldmL% 
nary capillary wedge pacssures. Cardiac oumt was deter- 
within lbss that wuz thm avem@ @rdiac output com- 
utter model 9510 A. Amaicm Edwards LabaatowI. A 
&ubletben&or coronary sinus catheter (Wilton W&&r 
Labmataics) vns intmduced perrutmeous~y tbmugb the 
sttbdavian vein into tbe distal uxmwy sinus to mawe 
commry sinus blood Row by the constant infttaion tbermwli- 
htti0n tahniqw and to ol:ain cmmary sinus vettw sam- 
pkr (13.14). To minim& cm nmy sinus retlux, the catheter 
was advanced under Suomscopic @idonce into tbc disml 
camnary sinus aml its p&ion cmt%med with a small b&s 
ofcon~mcdium.Theeprluoerwprpoeitionediathedistal 
mmnawsiwsitttheaestcardiactiaelimiIlareanv 
vcmxs cotdxibution fawn the ri&t ventricle M atrium. 
Sign&nut rdLu was fwtba eacluled by monitorinq the 
cbmgcs in ~tuatary siMs blwd temp&re dud6 an 
~~~dlOmlol*ed~incaolu(ionintotheryht, 
before md at the cmchtsim d the study (14. The radial 
at.xywascattmdatcdRx tnaamment d uterial pressure 
andsamp@dart&lbbmd. 
ARer a 1-h equilibmtim period, two basclinc bcmody- 
Ad MSP is n&t syst& prcsarc: oxmary sinus Hood 
Row (CSBF, mUmin) = [f& - T$f& - T,,J - I] x I.08 x 
56 mllmin, where Tb is tbe tempemtw of blood, Ti i the 
tempa’ature of Ihe btjecmtc and T,,, is tbc tempemnue dtbe 
mixture of blood and i@ctate. 1.08 is a eonstam w.coumipg 
tms~ilheatanddenrityofbothblwdand~a 
46mUministbcinjectbmmte&bebxiicam(%deaucae 
aad watcr) ChmuSb the Harvard constant im%sion pump. 
The metabolic vnliables were calcldated as folklw ox- 
ygen cmtent w 56) = axygeo sati x bentc-&lbol x 
1.34; mywarM mySea cmsumption (Mvq. mllmin) = 
@rtuial - commry oxy@n content) x CSBF x IO-‘; left 
vcntriculsr cSkimcy = (SW1 x WRy biVt&, wbcrc HR is 
myocxdial release of norepittephrine and epinephrbte 
flMRNE and TMRE, wxdively. w) was calculated 
as Larterial - ccmnaly sinus darewe @S/ml)] x CSBF 
bnUmin). Oxygm satmaims were maswcd with P Coming 
I75 automatic bk.xl d pH amlyzcr. Lactea ccxwmw&m 
N&inephdnc and epinepiuinc 
were measured by tiisotopc enzymatic assay (16). Na- 
mal laborstory vrduea in supine sub@% are @&rim. 
100 to 500 &ml. and cgbwpbrine, 35 to 16.5 pg$ml. In om 
&bomtory. mcasuremmts of plasma norqinephrine and 
euiineuhrine have a co&k111 of variation of 7% and II%, 
&eetively. Plasma concentrations cfawial nstriuretic fae- 
,or were detumined by radiinoassa~. Blocd wes WI- 
Iss(sd in chilled tubes and cemriruged pf i.CWl g for 10 mio 
a, Xc. plasma was sepsrwd and stored a, -2OT until 
assay. Atria1 na,riunxic factor was exhactcd by ose of C 
Sep-F’ak with a recovery role of&%. For the radioimmuoo- 
assay, rabbit antiserum to human atrial nahiwtic factor 
CRwarciY and Diagnostics, Inc.) was incubated in the pros- 
face of standard or sampk for 24 h. Labeled ‘%dineANF 
warLaaddedloeachsMlplsforanaddi,k&Z4-hiocuba- 
tionti4’c.F~andbaundfraclin.ofhumananialnaviuraic 
focIor wre sepsrared by precipitatian with ooa, anti~cum to 
Mobil iomuooglobulin G (second aotiiy): the incubation 
paiod wm 2 h al mrm tcm~rature. The mixtures were then 
cmbifwd, the supanatard dwnkd and the precipitates or 
buur~fraccionacol~ntcdina~amunta.~lhesenritivityd 
Ibis assay is 5 p%ubc. Intm- and inteiawy a&imts of 
variation Ml‘e 5% and I@& reapctively. 
SUisiM analysis. Dala lium each experimental period 
were ava’aged and expressed as mean value + SD. L&i- 
cal ooalysis wes conducted by using SAS General Linear 
Models procedure 6.06. lmmediare am, long-tam hemcdy- 
namic values rnrr ~plyzed by hvo-way analysis of variance 
for repeated measures MItwo facbws. If this pnalysia dem- 
0nstmte.l signifiwmce with no evidence of 881 inkmctica. P 
Donnctl test was applied for multiple caopairoor with 
basclinc. Myocardial coergetlc~l was aoalyzed by wing one- 
way mudysis of variaoce for rqaea,ed meawes 011 one 
pactor: time. If ,his aoalysis deraonstrpled s&ilkwe. B 
Donoett ter, was applied for o,okiple comparisoor &ost 
baseline. Correction for tissiog dote was otado es dowibed 
by Glaotz cod Slioker (17). Stolisticrd analysis of auiol 
nalri~~tic fPctm plsSma CO,,C.eMntims V/U maduaed by 
com@q baseline and pak e&t with the use of a tw 
tailed Sndenl paired, test. Peak dfecl was defined as the 
maGmaI decrease in M a&l pressure ;fmm the bardins 
value) after Bxequbmn adminirtntion. Statistical signib 
CMce was d&led as p c 0.05. 
Rem&3 
Syxkmk bcmady.&. Systemic boreline hemody- 
n&c valves did nu: diRe.r signillcwdly fmm the initbd 
values after 6 weeks of tbemjw (Tables I and 2). However, 
with the initial sod with the lrpcat administntioo offlose 
‘Mk 2. LOIE-TCITII Systemic Hemodymmic V&es Alla 6 We&s of Treatment WitL flmeqdnan 
nowi Aflu MnYS!mtiCa c4 !4aoxq&nn 
Bmd& 0, I 1.5 7. 4 6 i 
MAP,nnn “0 na * 11.4 73.9 t 10.9 13.7 * 11.1 74.4 * 11.9 73.7 t ,%,I 76.1 * 9.4 1.4 t 7.2 72.6 * 8.4 
HR ,bawmia1 (lstal 87 + 2, 85 t 19.4 8J t *, (6+1, s9* I7 8)t 111 93*24 
RAP,rmnH91 7.8 t II.* 7.4 + 8.2 7.0 * 8.0 4.9 f IJ 11.1 * 8.5 8.0*6.7 9J t 7.7 8.7 * 9.0 
PCwP*mHEl YEtI, 19.9 t ,,A I, r ,,J 17.9 t 9.9 2ut ,a5 lldf 11.7 ndt 12.1 2s * 162 
c, Qitenlnin, 2.34 + 040 zss tan 2.63+OA3 2.47 t OS7 *Jo* a52 X49PrO.4, *.,*&a 1s6fn.n 
.W (mUm3 3.4 f 9.3 31259.9 32.3 t 9.4 39.1 * ,a9 31.7 * 10 19.6 * 9.1 322*,, 10s ll.9 * 
SW ldyn.rs.m-I) ,c,9 * 4?4 1.2% t 4M I.204 t I,* 1.194 t: 34, ,,zZl * 374 ,297 * 311 LIP t 311 1,129 495 * 
WAPbnm H@ 11.1 * 11.1 31.3 * IS.6 29.5 * ,,A 11.9 f ,3J 31.4 + I4.I 34.1 * I4.d 39 * ISJ 74s t 11.1 
9VR Idynsrrm-9 a9.9 * 56 201 t 50 I67 I4s.I me96 ,*A** 19, +_ 39 ,87= fR7 117.9 t a 
*p < M.5 conwaed vah taelnr. Values are scam vahe * SD. Atbev*li, PI in Tak 1. 
quinabafler6 wseksoflhcmpyasimilarsigni6cant systemic 
hcmodynnmic &cl was Observed. The adminirMon Of 
fimequinan both immdiately and aflex6 wtekr srultcd in a 
sknblcant increase in cardiac. stroke volume and stroke 
pattern with an initial in- al 1 h afxer tbempyhnd a 
subscquenl inaeaae at 6 h. The cardiac i&x increased by 
Ml% in IOd 13 palients. AlIhougk the increase in cardii 
index was MI a%sozinled with a dmnge in mean arterial 
p-, the adminiatmtion d Ucquh rcsulad in a 
&mikant decrease in systemic vasadar resistance initially 
(1.544 f 413 to 1,247 i: 377 dyaesK’.cm-S. p c 0.05) with 
a similar response dwerved 6 weeks later. 
llleaCimi&mtilmofnOseqldwandidnOlresuhinan 
initial change in hurt rate: hmvever, *slight but ripificant 
RcressclnhesnMwasobsavedat4hw~h~s~~ 
up to 8 h afler both the initial and repeat adminislmticw of 
Aosquinan. Ri#n atrial mul pulmonary sa@ty wedge 
pressures (Q. 31 tended to decrsasc both bdtially and slla 
6 weeks of thcrspy. abbou& the decrease we wwisticnUy 
signilicsnt only at 1.5 b. &bl abial pressmw decreased in 
eight plienrs. No significant chant was observed in pul- 
monary artmy pressure; hOwcnw. pulmonary vascular esis- 
tance deaeased si@cmtly, both immediately and after 6 
ribongb nc4 siguliicamly 4th ibe miminiatrstim of llose 
quimm (Table 4). Anakl and camnary simw cpincpbriae 
arterial plasma levels of atrid naoiuretic factor. With the 
administration of llosequinan both the arterial and camnary 
sinus concmtmtions ol atrid oatriwrtic faam decreased 
significantly at peak&t in association with the decrease in 
lurid pRss”as (Table 5). However, the gradiea between 
camnary shws and arterial aoid naWiuretic faclor levels was 
not significantly ahead (Fig. 4). 
Discu~on 
s@emk~fDdlDllld~. Thepresti 
MIIIS dawnsbale that Uoseqoiom, a long-acting vasodila 
101. may be beneficial fa the hwkmmt of patients with 
congalive he& failure. Flazquinan therapy rewlad In B 
beneficid immediaa and long-term sustined systemic ha 
mc~echolamim telmce. 
Almost all patients had asignScant iucrease in cardiac 
i&x, stroke volume index and sbuke work index both 
immediately and with lcag-term &xquhum therapy. These 
he&Gal hemodynamic effects demonstrme M improw 
mat in cardiac performance with Rosequinnn that i; us- 
t&d afler loo@rm thempy. Although this was not a 
placcboaotrdled study, ho&cial kemodyoamic effecis 
were obxrved uoifonnly in the m@ity of patients !Ahio 
30 odn of &nioiswtion of Eosequioan. Thus, the observed 
hemodynamic &cts wn unlikdy to be a rcsuh of spmta- 
OODLLI changes OT physiologic inlerventions uch as feed@. 
PoEaiiaof~~gmr 
The mechanism 6x improved kfl ventricular petionnrure 
with llwqaioan is oot clear. Reduction in venbicolm oot- 
Ran impedance as a reroll of VasCUl~ Smooth muscle 
relax&m is P potentid mechanism as systemic vascular 
resistance did decrease with flosequinaa. Furthamore, 
lloseqoinan in this study demonstrated II wodoodoaol art* 
riolar vnscdilator action and odnioml veoodiluor e&cl ltll 
right an4 I& Riling pxersures did m% decrease signillcsotly, 
althou@ a trend was present. However. in s~dies by 
KeE.sler et al. (II) and Haas * al. (IS). p&ad was &Ii6 
cmtly reduced in patienls with congestive heat lbihve 
tread with Noseqoioon. 
Ahbough the heart rate did llot increase with Ibe initial 
hcmadynatnlc rerpmse. a small but dpbicaot late inwease 
inbcvtmtewasobsew?dafIertbeadminislrationdEoa~ 
i&id and late admini5ixntion of flow&an. was 
no signilicmt reduction in arterial pnswe. activntim of the 
immlwbx olechmdsm would not explahl ihe iocreaae in 
hean rate. Funhermmr, the increase in hean rate with the 
admini&ation of iiosequinan did noI appear to tc mediated 
by a change in plasma catecbdnmines as they did not change 
signifaantly. Thus, the nwdw&.m for the increase in heart 
rate with Rosquinan mmains unclear. An increase in heart 
nit.2 wiIh &xcquirmn therapy has teen repxted in normal 
volunteer8 as well as in p&ientr with congcstiw heat failure 
(3.19). In the study by H&u et al. (18) the heart rate 
were observed in 9 of 13 piicnts. This biphasic resp~nsr 
was not observed in pxviwr studies (3.18); however. in 
those studies hemmamic variables were only measured 
for 4 to 6 h &er tloxquinan administration. The ohserved 
biphasic hcmodynamic rewonse in w study is consistent 
ministration does IIOI immediately alter connary hem& 
namicr or increase myaudii oxygen consumption. Cca% 
nary sinus hIcod Row and myocmdii oxygen cnnnrmp(an 
did not change si,gdfiMaly with lloscquioan. ‘Ilnus, im- 
proved cardiac pedwmmu was not arsaintcd with in- 
creased metabolic ert. Indeed, the cdc&ted kfi venti- 
tar eiXcieixy index (ratio of minute work index IJ oxy$m 
conswnptic@ increwd si@iatly after Roscq&n. 
8s did the transmyocadia r&se doorepincphrine. altboo~h 
these cbmee~ MA not statistically ri&ant. These resolts 
suggest a rmsyq&etkaUy mediated improwmerd in sys. 
temk hemodyoamks with flosequinm. 
Arrlol nmiureric factor plasma concentrations in these 
patients were sigoiticantly elevated 1 baseline, a findbag 
con&tent with prior stodks in patiats with heart failure 
(Ii.20). In mo&ve hemi failure, arterial plasma atrial 
natriuretic laetor lmls comlnte tith increases in atria1 
pressure 0s atrial natrhuetic ffxtca is stored in gr8nuks in 
the atria and released in responx to atrial stretch (20). In our 
patients with severe kft ven~ricularfailure with ekvatcd kfI 
ventricular diastolic and I& atria1 tuessures, mmnmy sinus 
atria1 natrioretic fx.un mncent&ons were sigoiLnlly 
biiu than aterial ccitceotmtioos, indicating a signilksnt 
cotuttary sinus sampling WBJ from the guest cm&c vein; 
which npnsents veooos dmbmge predominantly from the 
left vcatricle. Thus, higher conmary sinus atrial nattiure$ic 
factor concentrarions in tbae p&eats with left ventrkulpr 
faihue suggest he release ofahial natriwetic fanop hum tbe 
kft ventricle. Although tbe mechmirm of atriai natriuretk 
factor release t%xn ti2 IelI ventrick is unknown. several 
iovestigaton CXL2) have rqmrted (he praence of increased 
immonoreactive ventricular pvial oaoiuretk factor io ho- 
mans and messenS5x ribonuclcic acid in models of prersurc 
OV&2Id. 
with bsequinan administratioo both arterial and mm- 
nary sious pksma avi.al oattiuretk factor kvels io these 
p8tiettt~ decreased si~td6c~otly at peak Cast rben atrial 
pressores were decreased maximally. As atrial navhurtic 
factor rckase occws in reqmsc to atrkl stretch, the ,edoc- 
ticm in right md letl atrial -urea at peak eflect with 
tlosequinao tberqy @ably malted in a decreased nlease 
of attial oatzioretic factor. A sigoiticmt reduction in the 
comnaty Shuts levels d atrial natrittmtic factor. wbicb 
‘CpMent the left hew catkibution to atrial natriwetic 
factor rekase, wss slso observed. Howver, tbc atrial nani- 
wetic factor arterial - cmonaty sinus gmdimt rempined 
canstmt, auggestinp e w&med kR heart contrtbmton to 
atrial nattiuntic factor dose in these patients with w 
tive heart faihue. Forlbwtttore.. the decrease in ahial natri- 
wetic factor levels is probably doe to cbaoges in systemic 
bemodymmi~ whb therapy sod unlikely to be reMr.d to any 
direct effecl of Rosequioao. 
Canctodoe. Florcqoimn therapy in patients with wn- 
ge.5tiVe heart failure resolts in a susained bendlfial bemo- 
dynamic action and improved ardiac performaoce witboot 
ss increase in myocardial oxygen demtmd. Fttrthattore, 
cmwtaty hemcdynamic states is oat altored and the sytnpa. 
thetk nerwos system does not appear to be activated with 
tIosewinm therapy. Thus, Roaequiom may bc usdul in fhc 
manwement ofpatkntn with coqtestive bat fnibue. 
